Genadijs Trofimovics

1Institute Of Oncology, Dzirciema Street 16
Riga, RIX 1007, Latvia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

The difference in contralateral breast cancer and ovarian cancer risks for BRCA1 founder variant (c.5266dup, c.4035del) carriers with primary breast cancer.

The difference in contralateral breast cancer and ovarian cancer risks for BRCA1 founder variant (c.5266dup, c.4035del) carriers with primary breast cancer.

Journal: BMC cancer

Published: January 28, 2025

Correction: Effectiveness of Secondary Risk-Reducing Strategies in Patients With Unilateral Breast Cancer With Pathogenic Variants of BRCA1 and BRCA2 Subjected to Breast-Conserving Surgery: Evidence-Based Simulation Study.

Correction: Effectiveness of Secondary Risk-Reducing Strategies in Patients With Unilateral Breast Cancer With Pathogenic Variants of BRCA1 and BRCA2 Subjected to Breast-Conserving Surgery: Evidence-Based Simulation Study.

Journal: JMIR formative research

Published: January 18, 2023

Effectiveness of Secondary Risk-Reducing Strategies in Patients With Unilateral Breast Cancer With Pathogenic Variants of BRCA1 and BRCA2 Subjected to Breast-Conserving Surgery: Evidence-Based Simulation Study.

Effectiveness of Secondary Risk-Reducing Strategies in Patients With Unilateral Breast Cancer With Pathogenic Variants of BRCA1 and BRCA2 Subjected to Breast-Conserving Surgery: Evidence-Based Simulation Study.

Journal: JMIR formative research

Published: February 18, 2022

Spectrum and frequency of CHEK2 variants in breast cancer affected and general population in the Baltic states region, initial results and literature review.

Spectrum and frequency of CHEK2 variants in breast cancer affected and general population in the Baltic states region, initial results and literature review.

Journal: European journal of medical genetics

Published: April 15, 2021

Ultrasound guided needle biopsy of axilla to evaluate nodal metastasis after preoperative systemic therapy in cohort of 106 breast cancers enriched with BRCA1/2 pathogenic variant carriers.

Ultrasound guided needle biopsy of axilla to evaluate nodal metastasis after preoperative systemic therapy in cohort of 106 breast cancers enriched with BRCA1/2 pathogenic variant carriers.

Journal: Hereditary cancer in clinical practice

Published: February 03, 2021

A novel frequent BRCA1 recurrent variant c.5117G > A (p.Gly1206Glu) identified after 20 years of BRCA1/2 research in the Baltic region: cohort study and literature review.

A novel frequent BRCA1 recurrent variant c.5117G > A (p.Gly1206Glu) identified after 20 years of BRCA1/2 research in the Baltic region: cohort study and literature review.

Journal: Hereditary cancer in clinical practice

Published: October 27, 2020

Body mass index and nipple preservation are major contributors to satisfaction and aesthetic outcome rates after implant-based immediate breast reconstruction.

Body mass index and nipple preservation are major contributors to satisfaction and aesthetic outcome rates after implant-based immediate breast reconstruction.

Journal: Contemporary oncology (Poznan, Poland)

Published: March 08, 2019

Allelic variants of breast cancer susceptibility genes PALB2 and RECQL in the Latvian population.

Allelic variants of breast cancer susceptibility genes PALB2 and RECQL in the Latvian population.

Journal: Hereditary cancer in clinical practice

Published: January 08, 2019

High frequency of pathogenic non-founder germline mutations in BRCA1 and BRCA2 in families with breast and ovarian cancer in a founder population.

High frequency of pathogenic non-founder germline mutations in BRCA1 and BRCA2 in families with breast and ovarian cancer in a founder population.

Journal: Hereditary cancer in clinical practice

Published: December 23, 2017

Underestimated survival predictions of the prognostic tools Adjuvant! Online and PREDICT in BRCA1-associated breast cancer patients.

Underestimated survival predictions of the prognostic tools Adjuvant! Online and PREDICT in BRCA1-associated breast cancer patients.

Journal: Familial cancer

Published: May 04, 2013

Prognostic role of BRCA1 mutation in patients with triple-negative breast cancer.

Prognostic role of BRCA1 mutation in patients with triple-negative breast cancer.

Journal: Oncology letters

Published: April 30, 2013

The first evidence of hereditary and familial gastric cancer in Latvia: implications for prevention.

The first evidence of hereditary and familial gastric cancer in Latvia: implications for prevention.

Journal: Medicina (Kaunas, Lithuania)

Published: August 14, 2012

Showing 1-12 of 15

Last Updated: 09/26/2026